Pimozide cf. Haloperidol in Tourette Syndrome
Pimozide (3.4 mg/day) and haloperidol (3.5 mg/day) therapy for Tourette syndrome were compared in a double-blind, 24-week, placebo-controlled crossover study of 22 patients, aged 7-16 years, at the Institute of Psychiatry, Charleston, SC.
| Autore principale: | |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Pediatric Neurology Briefs Publishers
1997-08-01
|
| Serie: | Pediatric Neurology Briefs |
| Soggetti: | |
| Accesso online: | https://www.pediatricneurologybriefs.com/articles/2363 |